It might also be speculated that the hyperinsulinemia in type2 diabetes mellitus or due to the excessive use of insulin to control hyperglycemia in diabetes mellitus might influence the development of breast cancer by impairing the systemic synthesis of maspin. This evidence concerns the gene INS and breast carcinoma.